Last updated: 2026-09-18 02:01:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
AETHLON MEDICAL INC. (AEMD) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $6.73, with a market capitalisation of $1.05M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.31 to $41.35. This page covers its latest market performance, valuation, price trends and company information.
$1.05M | |
$8.48 | |
$735,000.00 | |
$1.31 | |
$1.43 | |
91.37M | |
1.06M | |
-- | |
$41.35 | |
$1.31 | |
-- | |
-- |
AETHLON MEDICAL INC. (AEMD) last closed at $1.43 as of 2026-09-18 00:01:00, unchanged from the previous close of $1.43.
During the latest regular trading session, AEMD traded between $1.31 and $735,000.00, with a volume of 91.37M shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, AETHLON MEDICAL INC. (AEMD) moved from $1.81 to $6.73, representing a gain of 271.55% ($4.91).
The stock traded between $1.31 and $9.67 during the period. The latest price is near the middle of the 7-day range, indicating strong upward.
The average daily volume was 79.19 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 13.5%
AEMD is currently trading at $6.73, placing it 13.5% of the way from its 52-week low of $1.31 to its 52-week high of $41.35. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Aethlon Medical Inc is a medical therapeutic company focused on developing the Hemopurifier (HP), a clinical-stage investigational immunotherapeutic device designed to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation and other disease states in which extracellular vesicles (EVs) contribute to disease progression. The Hemopurifier utilizes a proprietary lectin-based technology to bind and remove enveloped viruses and EVs from biological fluids. EVs have been associated with immune suppression, metastasis, and resistance to therapy in cancer, as well as progression of severe infectious diseases. The Company operates as a single reportable segment.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 9 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of AETHLON MEDICAL INC. (AEMD) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.